WATSON 3359 WATSON 3359 Pill: pink, capsule/oblong, 14mm
The pill with imprint WATSON 3359 WATSON 3359 (Pink, Capsule/Oblong, 14mm) has been identified as Tacrolimus 5 mg and is used for Organ Transplant, Rejection Reversal, and Organ Transplant, Rejection Prophylaxis. It belongs to the drug class calcineurin inhibitors and is not a controlled substance.
Images for WATSON 3359 WATSON 3359
Tacrolimus
- Imprint
- WATSON 3359 WATSON 3359
- Strength
- 5 mg
- Color
- Pink
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Calcineurin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- National Drug Code (NDC)
- 00591-3359 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
croscarmellose sodium,
hypromelloses,
magnesium stearate,
gelatin,
titanium dioxide,
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Red No. 40
Note: Inactive ingredients may vary.
See also:
More about tacrolimus
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (50)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: calcineurin inhibitors
- Breastfeeding
- En español
Patient resources
- Tacrolimus oral and injection drug information
- Tacrolimus (Intravenous) (Advanced Reading)
- Tacrolimus (Oral) (Advanced Reading)
- Tacrolimus Capsules
- Tacrolimus Extended-Release Tablets
Other brands
Prograf, Envarsus XR, Astagraf XL, Hecoria
Professional resources
Other brands
Prograf, Envarsus XR, Astagraf XL
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.